American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 337-340 , September 2008

How to Ensure Our Readers' Trust: The Proper Attribution of Authors and Contributors

,Accepted 9 June 2008.

References 

  1. DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. 2008;299:1833–1835
  2. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to Rofecoxib: a case study of industry documents from Rofecoxib litigation. JAMA. 2008;299:1800–1812
  3. Rennie D, Yank V, Emmanuel L. When authorship fails: a proposal to make contributors accountable. JAMA. 1997;278:579–585
  4. Bhopal R, Rankin J, McColl E, et al. The vexed question of authorship: views of researchers in a British medical faculty. BMJ. 1997;314:1009–1012
  5. Goodman NW. Survey of fulfillment of criteria for authorship in published medical research. BMJ. 1994;309:1482
  6. Shapiro DW, Wenger NS, Shapiro MF. The contributions of authors of multiauthored biomedical research papers. JAMA. 1994;271:438–442
  7. Mowatt G, Shirran L, Grimshaw JM, et al. Prevalence of honorary and ghost authorship in Cochrane Reviews. JAMA. 2002;287:2769–2771
  8. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2006. http://www.icmje.orgAccessed: February 24, 2008
  9. Gøtzsche PC, Hróbjartsson A, Johansen HK, et al. Ghost authorship in industry-initiated randomized trials. PLoS Med. 2007;e19
  10. Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457–2465
  11. Cullen DJ. Ghostwriting in scientific anesthesia journals. Anesthesiology. 1997;87:195–196
  12. Claxton LD. Scientific authorship Part 2 (History, recurring issues, practices, and guidelines). Mutat Res. 2005;589:31–45
  13. Moffatt B, Elliott C. Ghost marketing: pharmaceutical companies and ghostwritten journal articles. Perspect Biol Med. 2007;50:18–31
  14. The World Association of Medical Editors. Ghost writing initiated by commercial companies. J Gen Intern Med. 2005;20:549
  15. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21:317–322
  16. Wager E. Authors, ghosts, damned lies, and statisticians. PLoS Med. 2007;4:e34
  17. Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin. 2003;19:149–154
  18. Sismondo S. Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?. PLoS Med. 2007;4:e286
  19. Bodenheimer T. Uneasy alliance—clinical investigators and the pharmaceutical industry. [Health Policy Report] N Engl J Med. 2000;342:1539–1544
  20. Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep. 2004;34:18–23
  21. Laine C, Mulrow CD. Exorcising ghosts and unwelcome guests. Ann Intern Med. 2005;143:611–612
  22. Ngai S, Gold JL, Gill SS, Rochon PA. Haunted manuscripts: ghost authorship in the medical literature. Account Res. 2005;12:103–114
  23. Woolley KL, Ely JA, Woolley MJ, et al. Declaration of medical writing assistance in international peer-reviewed publications. JAMA. 2006;296:932–934
  24. Healy DT. Transparency and trust: figure for ghost written articles was misquoted. BMJ. 2004;329:1345
  25. Mathews AW. Ghost story: at medical journals, writers paid by industry play big role. Wall Street Journal. 2005;A1;December 13
  26. Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature. 2005;435:737–738
  27. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280:222–224
  28. Mello MM, Clarridge BR, Studdert DM. Academic medical centers' standards for clinical-trial agreements with industry. N Engl J Med. 2005;352:2202–2210

PII: S0002-9394(08)00459-5

doi: 10.1016/j.ajo.2008.06.007

American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 337-340 , September 2008